United States Contraceptive Drugs Market Report 2017

October 2017 | 110 pages | ID: U1EAF265628WEN
QYResearch

Abstracts

In this report, the United States Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Contraceptive Drugs in these regions, from 2012 to 2022 (forecast).

United States Contraceptive Drugs market competition by top manufacturers/players, with Contraceptive Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Cipla
• Bayer
• Merck
• Teva Pharmaceutical
• Allergan
• Pfizer
• Reckitt Benckiser
• Mankind Pharma
• Janssen Pharmaceutical
• HLL Lifecare
• Mithra Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral Contraceptives
• Contraceptive Injectable
• Topical Contraceptive Patch

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Contraceptive Drugs for each application, including

• Hospital Pharmacy
• Independent Pharmacy
• Online Platform
• Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Contraceptive Drugs Market Report 2017

1 CONTRACEPTIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Contraceptive Drugs
1.2 Classification of Contraceptive Drugs by Product Category
  1.2.1 United States Contraceptive Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Contraceptive Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Contraceptives
  1.2.4 Contraceptive Injectable
  1.2.5 Topical Contraceptive Patch
1.3 United States Contraceptive Drugs Market by Application/End Users
  1.3.1 United States Contraceptive Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Independent Pharmacy
  1.3.4 Online Platform
  1.3.5 Clinics
1.4 United States Contraceptive Drugs Market by Region
  1.4.1 United States Contraceptive Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Contraceptive Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Contraceptive Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Contraceptive Drugs Status and Prospect (2012-2022)
  1.4.5 New England Contraceptive Drugs Status and Prospect (2012-2022)
  1.4.6 The South Contraceptive Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Contraceptive Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Contraceptive Drugs (2012-2022)
  1.5.1 United States Contraceptive Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Contraceptive Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES CONTRACEPTIVE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Contraceptive Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Contraceptive Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Contraceptive Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Contraceptive Drugs Market Competitive Situation and Trends
  2.4.1 United States Contraceptive Drugs Market Concentration Rate
  2.4.2 United States Contraceptive Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Contraceptive Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CONTRACEPTIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Contraceptive Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Contraceptive Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Contraceptive Drugs Price by Region (2012-2017)

4 UNITED STATES CONTRACEPTIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Contraceptive Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Contraceptive Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Contraceptive Drugs Price by Type (2012-2017)
4.4 United States Contraceptive Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CONTRACEPTIVE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Contraceptive Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Contraceptive Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CONTRACEPTIVE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Contraceptive Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Contraceptive Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Contraceptive Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceutical
  6.4.2 Contraceptive Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceutical Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.2 Contraceptive Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Contraceptive Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Reckitt Benckiser
  6.7.2 Contraceptive Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Reckitt Benckiser Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mankind Pharma
  6.8.2 Contraceptive Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mankind Pharma Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Janssen Pharmaceutical
  6.9.2 Contraceptive Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Janssen Pharmaceutical Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 HLL Lifecare
  6.10.2 Contraceptive Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 HLL Lifecare Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Mithra Pharmaceuticals

7 CONTRACEPTIVE DRUGS MANUFACTURING COST ANALYSIS

7.1 Contraceptive Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Contraceptive Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Contraceptive Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Contraceptive Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CONTRACEPTIVE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Contraceptive Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Contraceptive Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Contraceptive Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Contraceptive Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Contraceptive Drugs
Figure United States Contraceptive Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Contraceptive Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Contraceptives Product Picture
Figure Contraceptive Injectable Product Picture
Figure Topical Contraceptive Patch Product Picture
Figure United States Contraceptive Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Contraceptive Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Independent Pharmacy Examples
Table Key Downstream Customer in Independent Pharmacy
Figure Online Platform Examples
Table Key Downstream Customer in Online Platform
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure United States Contraceptive Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Contraceptive Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Contraceptive Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Contraceptive Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Contraceptive Drugs Sales Share by Players/Suppliers
Figure 2017 United States Contraceptive Drugs Sales Share by Players/Suppliers
Figure United States Contraceptive Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Contraceptive Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Contraceptive Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Contraceptive Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Contraceptive Drugs Revenue Share by Players/Suppliers
Table United States Market Contraceptive Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Contraceptive Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Contraceptive Drugs Market Share of Top 3 Players/Suppliers
Figure United States Contraceptive Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Contraceptive Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Contraceptive Drugs Product Category
Table United States Contraceptive Drugs Sales (K Units) by Region (2012-2017)
Table United States Contraceptive Drugs Sales Share by Region (2012-2017)
Figure United States Contraceptive Drugs Sales Share by Region (2012-2017)
Figure United States Contraceptive Drugs Sales Market Share by Region in 2016
Table United States Contraceptive Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Contraceptive Drugs Revenue Share by Region (2012-2017)
Figure United States Contraceptive Drugs Revenue Market Share by Region (2012-2017)
Figure United States Contraceptive Drugs Revenue Market Share by Region in 2016
Table United States Contraceptive Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Contraceptive Drugs Sales (K Units) by Type (2012-2017)
Table United States Contraceptive Drugs Sales Share by Type (2012-2017)
Figure United States Contraceptive Drugs Sales Share by Type (2012-2017)
Figure United States Contraceptive Drugs Sales Market Share by Type in 2016
Table United States Contraceptive Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Contraceptive Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Contraceptive Drugs by Type (2012-2017)
Figure Revenue Market Share of Contraceptive Drugs by Type in 2016
Table United States Contraceptive Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Contraceptive Drugs Sales Growth Rate by Type (2012-2017)
Table United States Contraceptive Drugs Sales (K Units) by Application (2012-2017)
Table United States Contraceptive Drugs Sales Market Share by Application (2012-2017)
Figure United States Contraceptive Drugs Sales Market Share by Application (2012-2017)
Figure United States Contraceptive Drugs Sales Market Share by Application in 2016
Table United States Contraceptive Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Contraceptive Drugs Sales Growth Rate by Application (2012-2017)
Table Cipla Basic Information List
Table Cipla Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Cipla Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Cipla Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Bayer Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Merck Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Merck Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Allergan Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Reckitt Benckiser Basic Information List
Table Reckitt Benckiser Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Mankind Pharma Basic Information List
Table Mankind Pharma Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceutical Basic Information List
Table Janssen Pharmaceutical Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table HLL Lifecare Basic Information List
Table HLL Lifecare Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Sales Growth Rate (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Sales Market Share in United States (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Revenue Market Share in United States (2012-2017)
Table Mithra Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Contraceptive Drugs
Figure Manufacturing Process Analysis of Contraceptive Drugs
Figure Contraceptive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Contraceptive Drugs Major Players/Suppliers in 2016
Table Major Buyers of Contraceptive Drugs
Table Distributors/Traders List
Figure United States Contraceptive Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Contraceptive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Contraceptive Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Contraceptive Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Contraceptive Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Contraceptive Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Contraceptive Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Contraceptive Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Contraceptive Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Contraceptive Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Contraceptive Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Contraceptive Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Contraceptive Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources